Tuesday, May 16 2023
01:31 PM – 01:55 PM PT
Alternative Conditioning Strategies and New Antibody Based Regimens
Megan D.. Hoban, PhD. Magenta Therapeutics, Cambridge, MA
Disclosures: M.D. Hoban: 1; Commercial Interest i.e. Company X; Magenta Therapeutics. 1; What was received? i.e. Honorarium; Salary, Equity. 1; For what role? i.e. Speaker; Current Employee. 2; Commercial Interest i.e. Company X; bluebird bio. 2; What was received? i.e. Honorarium; Salary, Equity. 2; For what role? i.e. Speaker; Former Employee.